Biotechnology EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Why Is Fusion Pharmaceuticals Stock Trading Higher Today? – AstraZeneca (NASDAQ:AZN), Fusion Pharmaceuticals (NASDAQ:FUSN) Read more
Stockmarkets AstraZeneca to buy Fusion Pharma for $2 billion in cash Reuters via biedexmarkets.com Read more
Biotechnology AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology AstraZeneca Beefs Up Its Endocrine Disease Pipeline With Amolyt Pharma Deal Worth $1.05B – AstraZeneca (NASDAQ:AZN) Read more
Stockmarkets AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio Reuters via biedexmarkets.com Read more
Biotechnology Nanotechnology’s Promising Role In Fighting Infectious Diseases: Protecting Surfaces With FendX’s Nanotechnology – AstraZeneca (NASDAQ:AZN), FendX Technologies (OTC:FDXTF) Read more
Biotechnology Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt ‘Barbell Approach’ – AstraZeneca (NASDAQ:AZN), ASML Holding (NASDAQ:ASML) Read more
Biotechnology Medicare’s Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more